Increased myocardial cathepsin D activity during regression of thyrotoxic cardiac hypertrophy.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D001835:Body Weight; D006332:Cardiomegaly / Q000201:enzymology* / Q000209:etiology / Q000378:metabolism; D002403:Cathepsins / Q000378:metabolism*; D003402:Creatine Kinase / Q000378:metabolism; D004195:Disease Models, Animal; D006352:Heart Ventricles / Q000473:pathology; D006596:Hexosaminidases / Q000378:metabolism; D006980:Hyperthyroidism / Q000139:chemically induced / Q000150:complications / Q000201:enzymology* / Q000378:metabolism; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D009206:Myocardium / Q000201:enzymology*; D009929:Organ Size; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012075:Remission, Spontaneous; D013974:Thyroxine
D011506:Proteins; D003402:Creatine Kinase; D000135:Acid Phosphatase; D006596:Hexosaminidases; D002403:Cathepsins; D013974:Thyroxine